These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36175079)

  • 1. Management of Metabolic Acidosis in Chronic Kidney Disease: Past, Present, and Future Direction.
    Goraya N; Narayanan M; Wesson DE
    Adv Chronic Kidney Dis; 2022 Jul; 29(4):416-423. PubMed ID: 36175079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dietary interventions to improve outcomes in chronic kidney disease.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2015 Nov; 24(6):505-10. PubMed ID: 26335553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism of Action of Veverimer: A Novel, Orally Administered, Nonabsorbed, Counterion-Free, Hydrochloric Acid Binder under Development for the Treatment of Metabolic Acidosis in Chronic Kidney Disease.
    Klaerner G; Shao J; Biyani K; Kade M; Kierstead P; Gbur R; Tabakman S; Nguyen S; Buysse J
    J Pharmacol Exp Ther; 2020 Dec; 375(3):439-450. PubMed ID: 33033169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does correction of metabolic acidosis slow chronic kidney disease progression?
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2013 Mar; 22(2):193-7. PubMed ID: 23380803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and population of the VALOR-CKD study: a multicenter, randomized, double-blind, placebo-controlled trial evaluating the efficacy and safety of veverimer in slowing progression of chronic kidney disease in patients with metabolic acidosis.
    Mathur VS; Bushinsky DA; Inker L; Klaerner G; Li E; Parsell D; Perkovic V; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Tangri N
    Nephrol Dial Transplant; 2023 May; 38(6):1448-1458. PubMed ID: 36331426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of veverimer on serum bicarbonate and physical function in diabetic patients with chronic kidney disease and metabolic acidosis: subgroup analysis from a randomized, controlled trial.
    Mathur VS; Li E; Wesson DE
    Nephrol Dial Transplant; 2022 Jun; 37(7):1302-1309. PubMed ID: 34240198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis.
    Tangri N; Mathur VS; Bushinsky DA; Klaerner G; Li E; Parsell D; Stasiv Y; Walker M; Wesson DE; Wheeler DC; Perkovic V; Inker LA
    J Am Soc Nephrol; 2024 Mar; 35(3):311-320. PubMed ID: 38261535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Kidney Int; 2014 Nov; 86(5):1031-8. PubMed ID: 24694986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Treatment of Metabolic Acidosis in CKD: A Systematic Review and Meta-Analysis.
    Navaneethan SD; Shao J; Buysse J; Bushinsky DA
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):1011-1020. PubMed ID: 31196951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fruit and Vegetable Treatment of Chronic Kidney Disease-Related Metabolic Acidosis Reduces Cardiovascular Risk Better than Sodium Bicarbonate.
    Goraya N; Munoz-Maldonado Y; Simoni J; Wesson DE
    Am J Nephrol; 2019; 49(6):438-448. PubMed ID: 30995657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veverimer: An Emerging Potential Treatment Option for Managing the Metabolic Acidosis of CKD.
    Adrogué HJ; Madias NE
    Am J Kidney Dis; 2020 Dec; 76(6):861-867. PubMed ID: 32920151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veverimer versus placebo in patients with metabolic acidosis associated with chronic kidney disease: a multicentre, randomised, double-blind, controlled, phase 3 trial.
    Wesson DE; Mathur V; Tangri N; Stasiv Y; Parsell D; Li E; Klaerner G; Bushinsky DA
    Lancet; 2019 Apr; 393(10179):1417-1427. PubMed ID: 30857647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine citrate excretion as a marker of acid retention in patients with chronic kidney disease without overt metabolic acidosis.
    Goraya N; Simoni J; Sager LN; Madias NE; Wesson DE
    Kidney Int; 2019 May; 95(5):1190-1196. PubMed ID: 30846270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of veverimer on serum bicarbonate and physical function in women with chronic kidney disease and metabolic acidosis: a subgroup analysis from a randomised, controlled trial.
    Mathur VS; Wesson DE; Tangri N; Li E; Bushinsky DA
    BMC Nephrol; 2022 Feb; 23(1):82. PubMed ID: 35216581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acid-base status and progression of chronic kidney disease.
    Goraya N; Wesson DE
    Curr Opin Nephrol Hypertens; 2012 Sep; 21(5):552-6. PubMed ID: 22874469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of treating metabolic acidosis in CKD stage 4 hypertensive kidney disease with fruits and vegetables or sodium bicarbonate.
    Goraya N; Simoni J; Jo CH; Wesson DE
    Clin J Am Soc Nephrol; 2013 Mar; 8(3):371-81. PubMed ID: 23393104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A basic solution for a complex problem: does treatment of metabolic acidosis slow CKD progression?
    Bodker K; Freidin N; Arora N
    Curr Opin Nephrol Hypertens; 2024 May; 33(3):304-310. PubMed ID: 38420899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful correction of metabolic acidosis is difficult to achieve in chronic kidney disease.
    Caravaca-Fontán F; Díaz-Campillejo R; Valladares J; López Arnaldo C; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(3):328-335. PubMed ID: 31862183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of Metabolic Acidosis as a Health Risk in Chronic Kidney Disease.
    Vincent-Johnson A; Scialla JJ
    Adv Chronic Kidney Dis; 2022 Jul; 29(4):329-336. PubMed ID: 36175070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.